glp-1 alzheimer's study Details of failed studies cast pall on Novo Nordisk's as treatment A doctor explains why GLP-1
Description
Copyright 2023 JPMorgan Chase & Co
An open-label, single-center, case-control pilot study investigated the effects of GLP-1RAs in individuals with idiopathic intracranial hypertension (IIH) and obesity (BMI 30 kg/m) [98] (Fig
It has been released and is available now
The best way is to go for symptomatic treatment after lifestyle modifications
Karwi QG, Uddin GM, Ho KL, Lopaschuk GD
